MDDI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Supplier Stories for the Week of July 22

Here’s what was new in the world of medical device suppliers during the week of July 22.

  • This is a compilation of the latest news from suppliers in the medical device industry.

    If you have news you’d like to submit for potential inclusion in this weekly roundup, please send a press release and any related images to [email protected] with the subject line “Supplier Stories.”


  • Contract manufacturer Web Industries Inc. will highlight its enhanced manufacturing capabilities for lateral flow immunoassay (LFI) devices at Booth #3861 at the upcoming AACC 70th Annual Scientific Meeting and Clinical Lab Expo, held July 29 to Aug. 2. 

    The company reports continuing investment in its new Lateral Flow Diagnostic Center of Excellence in Holliston, MA, which employs the latest advances in automation. The company’s medical division produces more than 1 billion clinical and diagnostic tests for device OEMs.

    “We are excited at the prospect of continuing this growth trend by helping our customers innovate and expand their businesses,” said Claudio Hanna, business development director, Web Industries, in a news release. “We have developed the process and know-how to successfully transition from prototyping to selling thousands and then millions of devices. They know they can count on us as a trustworthy partner on their device commercialization journey.”

    [Image courtesy of WEB INDUSTRIES INC.]


  • SYNEO has completed an expansion of its contract services lab in its Angleton, TX, facility.  Through this expansion, the company has increased the quick-turn material processing capabilities of its contract services division and increased the breadth of material processing services offered, including cut-to-length services, hole-making, slitting, tipping, grinding, and laser-based device marking, it was reported in a news release.

    “This expansion has allowed us to become a natural extension of our customers’ production capabilities by providing them with additional processing capabilities in short order when sudden changes in their respective capacity requirements arise,” said Tyler Wackman, SYNEO CEO, in the statement.

    SYNEO’s contract services division can process a wide range of medical grade materials, including single-lumen or multi-lumen tubing, wire-reinforced tubing, and nitinol wires. The division provides solutions for R&D applications, as well as long-term production support on established catheter-based products. The company maintains an ISO 7 Class 10,000 certified cleanroom and additional white-room space for contract service processing, with specific gowning, booties, gloves, masks, and footwear available to meet the specific needs requirements of the project.

    [Image courtesy of SYNEO]

  • West Pharmaceutical Services Inc. has announced the official opening of its new Waterford, Ireland, facility, a global center of excellence for West's advanced manufacturing network, and the launch of a new product line—Westar Select. Pictured above from the ribbon-cutting ceremony of the new facility are from left: Bernard Birkett, CFO, West; Mary Buckley, executive director, IDA Ireland; Cllr. Declan Doocey, mayor of Waterford City & County Council; John Halligan TD, minister of state for training, skills, innovation, research and development ; Don O'Callaghan, West VP operations, EU;  Mary Mitchell TD, minister of state, Dept. of Education; Eric Green, president and CEO, West; David Montecalvo, senior VP global operations & supply chain, West; Adam Wrench, director of operations, West; and Alain Wolf, site director, West. 

    "West is very pleased to celebrate the official opening of our state-of-the-art facility in Waterford, as well as the launch of Westar Select, both of which are the culmination of efforts by many to support our company's commitment to meeting the dynamic needs of our pharmaceutical and biotech partners," stated Green in news release. "Our investment in Waterford, in addition to our previously announced investments in Kinston, N.C., Jurong, Singapore, and Dublin, Ireland, enable West to provide the highest levels of quality across the products and services we provide for the global customer base we serve."

    The new, 20,500-sq-meter facility will produce West's proprietary elastomeric laminate sheeting, which is used to package insulin for use in pen injectors. It will also offer high-value finishing for components such as stoppers and plungers that are produced at other West facilities around the world.

    The Waterford site will also be among the first in West's global manufacturing network to produce Westar Select. "At West, we understand that our customers are increasingly challenged to meet new and expanding regulatory requirements, and with that comes an expectation for the highest quality in drug delivery and packaging components," added Montecalvo. "Westar Select employs next generation manufacturing capabilities and product attributes that enable us to optimize product specifications, and to respond more rapidly and flexibly to customer demand and evolving market needs."


  • Micronit, Axxicon, and Helvoet have launched Flow Alliance, House of Microfluidics. After working together for two years, the companies are now announcing their commitment to provide development and manufacturing support to meet growing global demand for high-quality high volume polymer microfluidic products. Such market growth is being driven by the development of new, fast diagnostic systems entering the healthcare market, the alliance reports in a news release. Polymer-based microfluidics can support these market needs through upscaling and cost advantages.

    The companies and their capabilities include:

    • Micronit provides lab-on-a-chip and MEMS solutions using micro and nano technologies in glass, silicon, polymers, or hybrid combinations.
    • Axxicon provides high-accuracy tooling and injection molding processes, specializing in combining micro and nano structures with high optical requirements.
    • Helvoet provides high-volume manufacturing of precision parts in a lean, high-quality, and clean environment with medical standards firmly in place.

    Combined, the Flow Alliance companies employ more than 800 people at various sites.

    Offering a single point of contact to microfluidic customers worldwide, the companies collaborate to provide support and capabilities over the full microfluidic value chain. Support includes a complete design center, prototyping, and production of validation samples as well as scalable technologies and processes to reliable volume manufacturing.  

    [Logo courtesy of FLOW ALLIANCE]

  • Sensirion offers the SPS30 particulate matter (PM) sensor employing the company’s contamination-resistance technology. Traditional optical PM sensors can suffer from contamination, which can cause output degradation, the company reports. With a lifetime of more than eight years, the SPS30 relies on advanced algorithms for different PM types and higher-resolution particle size binning, opening up new possibilities for the detection of different sorts of environmental dust and other particles. With dimensions of only 41 x 41 x 12 mm3, it is suited for applications where size is of paramount importance, such as wall-mounted or compact air quality devices.

    Sensirion offers a product range including gas and liquid flow sensors, differential pressure sensors, and environmental sensors for the measurement of humidity and temperature, volatile organic compounds (VOC), carbon dioxide (CO2), and particulate matter. Products use CMOSens technology, which permits intelligent system integration of the sensor element, logic, calibration data, and a digital interface on a single chip. Sensirion sensors have been used in the medical, industrial, and other sectors.

    {imafe courtesy of SENSIRION] 

Daphne Allen

Daphne Allen is editor-in-chief of MD+DI. She previously served as executive editor of Pharmaceutical & Medical Packaging News, which serves as the pharmaceutical and medical device channel of Packaging Digest. Daphne has covered medical device manufacturing, packaging, labeling, and regulatory issues as well as pharmaceutical packaging and labeling for more than 20 years. She is also a member of the Institute of Packaging Professionals's Medical Device Packaging Technical Committee. Follow her on Twitter at @daphneallen.


Filed Under
500 characters remaining